Skip to content
★ Sign in to follow
EC

Edward C. Albini

CFO
Chief Financial Officer
Sutro Biopharma, Inc.Paratek Pharmaceuticals, Inc.
Total declarations
50
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€117k

Latest filing published 19 May 2025 for Sutro Biopharma, INC..

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Edward C. Albini: trading record in brief

This profile gathers the share dealings of Edward C. Albini across 2 companies, led by Sutro Biopharma, Inc. and Paratek Pharmaceuticals, Inc. In total, 50 filings cover trades dated from 26 September 2007 to 15 May 2025.

The open-market record consists of 4 sales worth €117k, with no purchase. Other entries cover 18 share grants and 27 option exercises.

On 19 May 2025 came the latest disclosure, an option exercise in Sutro Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Edward C. Albini

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations50 total

25 of 50 declarations